1992Japanese Journal of Hospital PharmacyOpen access

Acquisition of Resistance to Beta-Lactams by Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens.

Yoshikazu Ishii, Mitsuo Kaku, Masataka Ichikawa

Open full text 0 citations

Abstract

Mutants derived from Enterobacter cloacae ATCC 23355 and Serratia marcescens ATCC 8100 by treatment with ceftizoxime were found to be resistant to various newer beta-lactam antibiotics, except for imipenem. E.cloacae ATCC 23355M as a mutant showed no changes in beta-lactamase production and activity during serial passages of the, strain, indicating that its acquisition of resistance was due to chromosomal mutation.In contrast, there was no change in beta-lactamase production by S.marcescens ATCC 8100M in comparison with S.marcescens ATCC 8100 as a parent strain.Mutants of both S. marcescens ATCC 8100 and E.cloacae ATCC 23355 showed changes in their major outer membrane proteins. These findings suggested that the acquisition of resistance to the newer beta-lactam antibiotics by S.marcescens and E.cloacae was dependent on changes of their major outer membrane proteins or changes of beta-lactamase production.

Open-access reader

About this research paper

What this paper is about

Mutants derived from Enterobacter cloacae ATCC 23355 and Serratia marcescens ATCC 8100 by treatment with ceftizoxime were found to be resistant to various newer beta-lactam antibiotics, except for imipenem. E.cloacae ATCC 23355M as a mutant showed no changes in beta-lactamase production and activity during serial passages of the, strain, indicating that its acquisition of resistance was due to chromosomal mutation.In contrast, there was no change in beta-lactamase production by S.marcescens ATCC 8100M in comparison with S.marcescens ATCC 8100 as a parent strain.Mutants of both S. marcescens ATCC 8100 and E.cloacae ATCC 23355 showed changes in their major outer membrane proteins. These findings suggested that the acquisition of resistance to the newer beta-lactam antibiotics by S.marcescens and E.cloacae was dependent on changes of their major outer membrane proteins or changes of beta-lactamase production.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Mutants derived from Enterobacter cloacae ATCC 23355 and Serratia marcescens ATCC 8100 by treatment with ceftizoxime were found to be resistant to various newer beta-lactam antibiotics, except for imipenem. E.cloacae ATCC 23355M as a mutant showed no changes in beta-lactamase production and activity during serial passages of the, strain, indicating that its acquisition of resistance was due to chromosomal mutation.In contrast, there was no change in beta-lactamase production by S.marcescens ATCC 8100M in comparison with S.marcescens ATCC 8100 as a parent strain.Mutants of both S. marcescens ATCC 8100 and E.cloacae ATCC 23355 showed changes in their major outer membrane proteins. These findings suggested that the acquisition of resistance to the newer beta-lactam antibiotics by S.marcescens and E.cloacae was dependent on changes of their major outer membrane proteins or changes of beta-lactamase production.

Key concepts: Serratia marcescens, Enterobacter cloacae, Microbiology, Citrobacter freundii, Imipenem, Enterobacteriaceae, Biology, Antibiotics

Related papers

Back to paper searchBrowse research topicsOriginal source
Acquisition of Resistance to Beta-Lactams by Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens. — Research Paper | ScholarLens